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Absence of Epstein-Barr virus in oesophageal
squamous cell carcinoma
K Y Lam, G Srivastava, M L Leung, L Ma
Abstract
Aim-To identify the possible role of
Epstein-Barr virus (EBV), in Chinese
patients, in the pathogenesis of oeso-
phageal squamous cell carcinoma.
Methods-Formalin fixed, paraffin wax
embedded tissues from 74 cases of oes-
ophagealsquamous cellcarcinoma (28 with
well differentiated, 27 with moderately
differentiated and 18 with poorly differ-
entiated carcinomas) were analysed for
EBV using in situ hybridisation for EBV
encoded small RNAs.
Results-EBV was detected in only a few
lymphocytes adjacent to the tumour epi-
thelia in 14 (19%) cases of oesophageal
carcinoma. The adjacent, non-patho-
logical oesophageal tissue was EBV
negative.
Conclusions-EBV does not play a major
role in the aetiology ofoesophageal squam-
ous cell carcinoma.
(J7 Clin Pathol: Mol Pathol 1995;48:M188-M19O)
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Oesophageal cancer is a disease of high in-
cidence and mortality in many regions of the
world.' In Hong Kong, this disease is the sixth
most common cause of death due to cancer.
Epidemiological and experimental studies have
suggested that some chemical agents, nu-
tritional deficiencies and physical factors are
associated with the development of oes-
ophageal cancer3; however, they have failed to
isolate the definite aetiological agent of oes-
ophageal cancer. There is some evidence that
certain micro-organisms, such as several vir-
uses, fungi and bacteria, have an aetiological
role in the carcinogenesis of oesophageal can-
cer. Of these micro-organisms, the relation
between human papillomavirus (HPV) and
oesophageal cancer has been studied most ex-
tensively. Nevertheless, in a study a few years
ago we failed to demonstrate HPV using DNA
slot blot analysis and in situ hybridisation (ISH)
in oesophageal squamous cell carcinomas in
Hong Kong Chinese.4 One possible limitation
of that study was that these methods lacked
sensitivity as the polymerase chain reaction
(PCR) was not used to amplify the DNA.
The close proximity of the oesophagus to the
nasopharynx raises the possibility that Epstein-
Barr virus (EBV) may be involved in the car-
cinogenesis of oesophageal cancer. EBV is a
ubiquitous human herpes virus; over 90% of
adults worldwide are seropositive for EBV.5
This virus shows tropism for both lymphoid
and epithelial cells, and it is classically as-
sociated with nasopharyngeal carcinoma and
Burkitt's lymphoma. Recent studies have in-
dicated that EBV may be implicated in the
pathogenesis of oral hairy leukoplakia in
patients with AIDS, lymphoproliferative dis-
orders in immunocompromised patients as
well as other lymphoid and epithelial malig-
nancies.68 The EBV related lymphoid malig-
nancies include Hodgkin's disease, T cell
lymphomas, nasal lymphomas of T and natural
killer cell phenotype, some B cell lymphomas,
and lymphomas arising in organ transplant
recipients and immunocompromised patients
(including those with AIDS). EBV related
carcinomas usually resemble nasopharyngeal
carcinomas, being undifferentiated and with
a prominent lymphoid stroma (lympho-
epithelioma-like/undifferentiated carcinoma).
They include undifferentiated carcinomas
especially those of foregut origin (for example,
salivary gland, stomach, thymus, and lung).8-'3
Recently, EBV was demonstrated in the nuc-
lei of carcinoma cells using ISH in a Japanese
patient with undifferentiated carcinoma of the
oesophagus.'4 To our knowledge, EBV has not
been demonstrated in cases of oesophageal
squamous cell carcinoma to date. Hong Kong
has a high incidence of oesophageal carcinoma
and nasopharyngeal carcinoma in comparison
with Western countries'5 and nearly all of
the nasopharyngeal carcinomas in Hong Kong
are EBV positive. Thus, the aim of this study
was to determine whether EBV has a role in
the aetiology of squamous cell carcinoma in
Hong Kong Chinese.
Methods
Seventy four cases (62 men and 12 women)
of oesophageal squamous cell carcinoma were
retrieved from the files of the Department of
Pathology at Queen Mary's hospital. The
patients had undergone surgery between 1990
and 1993, and ranged in age from 39 to 89
years (mean 63 years). Tissue was excised from
the upper portion of the oesophagus in six (8%)
cases, from the mid portion in 44 (60%) and
from the lower portion in 24 (32%). Haema-
toxylin and eosin stained sections were re-
viewed and the diagnosis confirmed. Of the 74
cases, 28 (38%) had well differentiated, 27
(36%) had moderately differentiated and 19
(26%) had poorly differentiated squamous cell
carcinoma. The degree oflymphoid infiltration
was also noted for each case.
Sections (5 jim) from representative blocks
were deparaffinised, rehydrated and pretreated
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EBER-ISH in a case of oesophageal squamous cell carcinoma. Note the positive reaction
(arrow) in the nucleus of a lymphocyte in the tumour stroma. (Original magnification
x 500.)
with proteinase K (Sigma, St Louis, Missouri,
USA, P8038). ISH for EBV encoded small
RNAs (EBERs) was then performed on these
sections using the EVB-ISH kit from Dako
(Kyoto, Japan), in RNase-free conditions at
room temperature according to the man-
ufacturer's instructions. The fluorescein con-
jugated EBER oligonucleotide probe was
detected using alkaline phosphatase conjugated
rabbit anti-fluorescein isothiocyanate antibody
(Fab2 fragment). Nitro blue tetrazolium,
together with 5-bromo-4-chloro-3-indolyl-
phosphate (BCIP), was used as substrate and
a case of nasopharyngeal carcinoma served as a
positive control. The slides were then mounted
and examined. Positive staining was regarded
as black colour at the site of hybridisation.
Results
None of the epithelial cells in the 74 cases
of oesophageal squamous cell carcinoma was
positive for EBV. Strong signals were observed
in the nuclei of the tumour cells in the control
case of nasopharyngeal carcinoma, dem-
onstrating the specificity of this technique in
detecting EBV. Positive signals with the EBER
probe were also seen in occasional infiltrating
lymphocytes in the tumour stroma (figure) of
14 oesophageal squamous cell carcinomas (five
well differentiated, two moderatively differ-
entiated and six poorly differentiated). The
number of lymphocytes positive for EBER was
less than five in all except one case in which
12 lymphocytes were positive. A large portion
ofthese cases were poorly differentiated squam-
ous cell carcinomas (43%) although there was,
in fact, no significant correlation between
tumour differentiation and the presence ofEBV
positive lymphoid cells (p>0. 1; Fisher's exact
test). All cases with EBV positive lymphocytes
had a moderate to severe lymphoid infiltrate
around the clusters of tumour cells. However,
a mild to moderate lymphoid infiltrate was
also noted in the stroma of other tumours. In
addition, there was no significant difference
between those patients with or without EBER
positive lymphocytes with respect to age (p=
0 40; Student's t test), sex (p=0 44; Fisher's
exact test) or tumour site (p = 099; Fisher's
exact test).
Discussion
EBV DNA has been found in diverse sites of
the body in patients without apparent EBV
related diseases.'6 It has been detected in our
department by PCR in the upper digestive
tract-for example, salivary glands, tonsils,
nasopharynx, and larynx. The proximity of
these organs may suggest that the oesophagus
may also harbour EBV. EBV has also been
demonstrated in oesophageal epithelial cells in
some cases of AIDS associated oesophageal
ulceration.'7 In the present study, however,
EBV was not detected in normal oesophageal
epithelium. EBV, if present, is more likely to
be found in infiltrating lymphocytes rather than
in epithelial cells. It could also be argued that
EBV is present at a level below the detection
threshold of ISH.
Mori et al'4 detected EBV using ISH in a
case ofoesophageal undifferentiated carcinoma
(lymphoepithelioma-like carcinoma) but in
none of 29 cases of squamous cell carcinoma.
The absence of EBV RNA in the tumour cells
of oesophageal squamous cell carcinomas in
the present study also suggests that EBV does
not play a significant role in the pathogenesis
of this tumour. These findings concur with
those ofWong et all' who studied oesophageal
carcinoma cell lines of Chinese origin.
The significance of positive signals in oc-
casional lymphocytes in the stroma ofthe some
cases of oesophageal squamous cell carcinoma
remains unclear but may indicate a previous
EBV infection. Those positive signals, present
in carcinoma rather than normal cells, may
reflect the presence of more EBV positive lym-
phocytes in oesophageal carcinomas and thus
a greater chance of picking up EBER positive
cells. However, a remote possibility that EBV
acts as a cofactor in the carcinogenesis of
oesophageal carcinoma cannot be excluded
completely. EBV may alter the tissue mi-
croenvironment and thus affect the sus-
ceptibility of oesophageal epithelial cells to
carcinogens.
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